Effort is part of the Accelerating Medicines Partnership to speed development of disease-altering treatments.
Bethesda, Maryland—(ENEWSPF)—January 30, 2018
By: NIH Office of Communications
The National Institutes of Health is teaming with government, biopharmaceutical, life science and non-profit organizations to overcome obstacles and increase success for advancing promising treatments for Parkinson’s disease (PD). Part of the NIH Accelerating Medicines Partnership (AMP), AMP PD will focus on identifying and validating promising markers of disease…
